In a report released today, David Steinberg from Jefferies reiterated a Hold rating on Perrigo Company plc (NYSE: PRGO), with a price target of $73. The company’s shares opened today at $69.01, close to its 52-week low of $67.69.
According to TipRanks.com, Steinberg is a 4-star analyst with an average return of 10.5% and a 49.6% success rate. Steinberg covers the Healthcare sector, focusing on stocks such as Bausch Health Companies Inc, Supernus Pharmaceuticals, and Collegium Pharmaceutical.
The word on The Street in general, suggests a Hold analyst consensus rating for Perrigo Company plc with a $81.67 average price target, implying a 18.3% upside from current levels. In a report issued on July 30, Argus Research also downgraded the stock to Hold.
.
See today’s analyst top recommended stocks >>
Perrigo Company plc’s market cap is currently $9.78B and has a P/E ratio of 76.96. The company has a Price to Book ratio of 1.58.
Based on the recent corporate insider activity of 79 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PRGO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals.
